Clofazimine‐induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross‐sectional study

• DOI: 10.1111/tmi.13977
• Publication Date: 2024-02-13T09:25:33Z
• Authors: Andreza Soares No...; Monique Allana Ch...; Moises Batista da...; Patricia Fagundes...; Marco Andrey Cipr...; Claudio Guedes Sa...; Josafá Gonçalves ...
• Keywords: Clofazimine; Cross-sectional study; Stigma

Cutaneous hyperpigmentation is one of the main adverse effects encountered in patients undergoing leprosy treatment with multidrug therapy (WHO-MDT). This effect has been described as intolerable and capable contributing to social stigma. The objectives this study were quantify variation skin colour induced by clofazimine during after assess related